Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL987284 | 0.87 | PKM (0.41) | DPP4PKM | |
| SCHEMBL1733050 | 0.84 | PKM (0.39) | DPP4PKM | |
| SCHEMBL4054948 | 0.82 | EPHX2 (0.35) | DPP4PKM | |
| SCHEMBL4059154 | 0.82 | GRIN1 (0.42) | — | |
| SCHEMBL6766012 | 0.81 | DPP4 (0.35) | DPP4PKM | |
| SCHEMBL4063745 | 0.79 | PKM (0.41) | DPP4PKM | |
| SCHEMBL3843165 | 0.73 | — | — | |
| SCHEMBL18543254 | 0.72 | LMNA (0.41) | DPP4PKM | |
| SCHEMBL3332166 | 0.72 | LMNA (0.41) | DPP4PKM | |
| SCHEMBL18543255 | 0.72 | LMNA (0.41) | DPP4PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107602345-A | A kind of method for synthesizing di- adamantane glycol and its derivative | 上海博栋化学科技有限公司 | 2018-01-19 | — | — | CN | claimed |
| CN-107602345-A | A kind of method for synthesizing di- adamantane glycol and its derivative | 上海博栋化学科技有限公司 | 2018-01-19 | — | — | CN | disclosed |
| US-20090318610-A1 | ORGANIC INSULATING MATERIALS, VARNISHES FOR ORGANIC INSULATING FILM EMPLOYING THEM, ORGANIC INSULATING FILMS AND SEMICONDUCTOR DEVICES | SUMITOMO BAKELITE CO., LTD (JP) | 2009-12-24 | — | — | US | disclosed |
| EP-2117009-A1 | ORGANIC INSULATING MATERIAL, VARNISH FOR ORGANIC INSULATING FILM USING THE SAME, ORGANIC INSULATING FILM AND SEMICONDUCTOR DEVICE | Sumitomo Bakelite Co., Ltd. (JP) | 2009-11-11 | — | — | EP | disclosed |
| US-20090030248-A1 | Ethynylphenylbiadamantane derivatives | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2009-01-29 | — | — | US | disclosed |
| EP-2014636-A1 | Ethynylphenylbiadamantane derivatives | Daicel Chemical Industries, Ltd. (JP) | 2009-01-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090030248-A1 | Ethynylphenylbiadamantane derivatives | CHRNA5, CHRNE, ADRA1D | DPP4 2292/4885PKM 4221/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.